This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

GlaxoSmithKline PLC (GSK)

NYSE: Health Care

Get a 5-page Ratings Report on (GSK) now
$55.30
04/22/14 - 4:01 PM ET
  • Latest Dividend: 0.75
  • Latest Dividend Yield: 4.51%
  • Dividend Ex-Date: 02/19/14
  • Price Earnings Ratio: 18.8144
  • Price Earnings Comparisons:
    GSK Sector Avg. S&P 500
    18.81 14.60 29.20
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    1.02% 9.18% 33.64%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 2.30 0.00 0.00
    Net Income 21.10 2.25 0.47
    EPS 23.20 2.75 0.55
  • Earnings for GSK:
    EBITDA 11.43B
    REVENUE 43.71B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.72 $0.81 $3.61 $3.93
Number of Analysts 3 2 8 7
High Estimate $0.80 $0.84 $3.77 $4.16
Low Estimate $0.68 $0.78 $3.37 $3.65
Prior Year $0.82 $0.80 $3.46 $3.61
Growth Rate (Year over Year) -11.79% 1.25% 4.37% 8.95%
(GSK) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,514.37 +65.12 0.40%
S&P 500 1,879.55 +7.66 0.41%
NASDAQ 4,161.4580 +39.9120 0.97%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs